Bristol-Myers Squibb Co at UBS BioPharma Conference Transcript
Okay. It's 8:00 a.m. My name is Trung Huynh. I'm one of the therapeutics analyst here at UBS. It's my great pleasure to present to you guys Bristol-Myers Squibb, our first fireside session, our conference.
Today, we're talking about cell therapy for the next 45 minutes. We've got Lynelle Hoch, who is the Head of Cell Therapy at BMY, and we've also got IR here in the room. Welcome.
Thank you. Great to be here.
Questions & Answers
You guys are one of the pioneers of cell therapy. When I first looked at cell therapy, I thought to myself, my God, this is not going to work. And there were many challenges. Challenges around manufacturing, challenges around vector, supply, reimbursements, you guys have made significant progress over the last 5 years to try to address all of these
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
